Related Experiment Videos
The response of breast cancer cells to steroid and peptide growth factors
Abstract:
Four breast cancer cell lines covering a wide range of receptor characteristics were examined for their growth responses to oestradiol, insulin, EGF and the anti-oestrogen, tamoxifen. Stimulated cellular growth using both the MTT assay and 3H-thymidine incorporation into DNA, was measured against controls grown in a steroid reduced environment. The ER positive MCF-7 cell line showed clear growth responses to E2, insulin and EGF. This was also demonstrated, although to a lesser extent in the ZR-75-1 line which expresses lower levels of ER. In combination, these factors gave an additive growth response but the addition of EGF to maximal concentrations of insulin and oestradiol produced no further increase in growth. In contrast to these results, the two ER negative cell lines examined, MCF-7 Adr and MDA-MB-231 showed no growth response to exogenously applied steroids and in the case of MCF-7 Adr high concentrations of EGF were able to inhibit the growth of this cell line. They also showed high rates of growth in a steroid depleted environment which tends to suggest these cells are growing autonomously through autocrine growth factor induction.
Insights
Estrogen receptor (ER) positive breast cancer cells show growth responses to estradiol, insulin, and EGF. ER-negative cells exhibit autonomous growth, suggesting autocrine signaling.
Area of Science:
- Oncology
- Cell Biology
- Endocrinology
Background:
- Breast cancer cell growth is influenced by various growth factors and hormones.
- Estrogen receptor (ER) status is a key determinant in breast cancer progression and treatment response.
- Understanding differential growth factor responses in ER-positive versus ER-negative cells is crucial for targeted therapies.
Purpose of the Study:
- To investigate the differential growth responses of breast cancer cell lines with varying ER expression to estradiol (E2), insulin, epidermal growth factor (EGF), and tamoxifen.
- To elucidate the mechanisms of growth regulation in ER-positive and ER-negative breast cancer cells.
- To assess the potential for autonomous growth in ER-negative cell lines.
Main Methods:
- Utilized four breast cancer cell lines with diverse receptor characteristics.
- Assessed cellular proliferation using MTT assay and 3H-thymidine incorporation.
- Cultured cells in a steroid-reduced environment to evaluate growth factor dependency.
- Administered estradiol, insulin, EGF, and tamoxifen to assess their effects on cell growth.
Main Results:
- ER-positive MCF-7 cells demonstrated significant growth stimulation by E2, insulin, and EGF.
- ZR-75-1 cells, with lower ER levels, showed a lesser but notable response to these factors.
- Combined growth factor treatment yielded additive effects, with EGF not further enhancing maximal E2 and insulin responses.
- ER-negative MCF-7 Adr and MDA-MB-231 cells exhibited no response to exogenous steroids and, in the case of MCF-7 Adr, growth inhibition by high EGF concentrations.
- ER-negative cells displayed robust growth in steroid-depleted conditions, indicating potential autocrine signaling.
Conclusions:
- Breast cancer cell growth is differentially regulated by hormonal and growth factor signaling based on ER status.
- ER-positive cells are responsive to external stimuli like estradiol, insulin, and EGF.
- ER-negative breast cancer cells may possess intrinsic growth factor signaling pathways, leading to autonomous proliferation.
- These findings highlight distinct therapeutic vulnerabilities and suggest autocrine mechanisms in ER-negative breast cancer.